Literature DB >> 1398954

Recombinant interleukin-1 alpha augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani.

A J Curry1, P M Kaye.   

Abstract

In vivo administration of various doses of recombinant interleukin-1 alpha to B10.D2/n mice chronically infected with Leishmania donovani resulted in enhanced formation of granulomas and in vitro production of gamma interferon. By direct microscopical enumeration, reduction in gross parasite burden in the viscera was not observed, however. These data highlight an important discordance between granuloma formation per se and parasite elimination and suggest that interleukin-1 deficiency alone cannot account for the chronicity of this disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1398954      PMCID: PMC257483          DOI: 10.1128/iai.60.10.4422-4426.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  Antigen processing and presentation: modelling with Leishmania.

Authors:  P M Kaye; A J Curry; G J Bancroft; T Lang
Journal:  Behring Inst Mitt       Date:  1991-02

2.  Role of TNF and IL-1 in infections with Toxoplasma gondii.

Authors:  H R Chang; G E Grau; J C Pechère
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

3.  Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.

Authors:  N E Reiner; W Ng; C B Wilson; W R McMaster; S K Burchett
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.

Authors:  H W Murray; H Masur; J S Keithly
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2.

Authors:  J Kaye; S Gillis; S B Mizel; E M Shevach; T R Malek; C A Dinarello; L B Lachman; C A Janeway
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

6.  Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains.

Authors:  T I Roach; A F Kiderlen; J M Blackwell
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani.

Authors:  W Y Weiser; L M Pozzi; J R David
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

8.  Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.

Authors:  P M Kaye; A J Curry; J M Blackwell
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

9.  Altered course of visceral leishmaniasis in mice expressing transgenic I-E molecules.

Authors:  P M Kaye; A Cooke; T Lund; M Wattie; J M Blackwell
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

10.  Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin.

Authors:  N E Reiner; J H Finke
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

View more
  10 in total

Review 1.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.

Authors:  Henry W Murray; Christina M Lu; Smita Mauze; Sherry Freeman; Andre L Moreira; Gilla Kaplan; Robert L Coffman
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  CD4(+) cells are indispensable for ulcer development in murine cutaneous leishmaniasis.

Authors:  M Terabe; T Kuramochi; M Ito; T Hatabu; C Sanjoba; K P Chang; T Onodera; Y Matsumoto
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

Review 4.  Tissue granuloma structure-function in experimental visceral leishmaniasis.

Authors:  H W Murray
Journal:  Int J Exp Pathol       Date:  2001-10       Impact factor: 1.925

5.  TGF-beta and mesenchymal hepatic involvement after visceral leishmaniasis.

Authors:  Maria Irma Seixas Duarte; Heitor Franco de Andrade; Cleusa Fumica Hirata Takamura; Antonio Sesso; Felipe Francisco Tuon
Journal:  Parasitol Res       Date:  2008-12-05       Impact factor: 2.289

6.  Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.

Authors:  Lynette Beattie; Adam Peltan; Asher Maroof; Alun Kirby; Najmeeyah Brown; Mark Coles; Deborah F Smith; Paul M Kaye
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

Review 7.  Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.

Authors:  Alti Dayakar; Sambamurthy Chandrasekaran; Suresh V Kuchipudi; Suresh K Kalangi
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

8.  Unravelling the unsolved paradoxes of cytokine families in host resistance and susceptibility to Leishmania infection.

Authors:  Bernard Ong'ondo Osero; Raphael Taiwo Aruleba; Frank Brombacher; Ramona Hurdayal
Journal:  Cytokine X       Date:  2020-12

9.  Functional complexity of the Leishmania granuloma and the potential of in silico modeling.

Authors:  John W J Moore; Daniel Moyo; Lynette Beattie; Paul S Andrews; Jon Timmis; Paul M Kaye
Journal:  Front Immunol       Date:  2013-02-15       Impact factor: 7.561

10.  CD4+ Recent Thymic Emigrants Are Recruited into Granulomas during Leishmania donovani Infection but Have Limited Capacity for Cytokine Production.

Authors:  John W J Moore; Lynette Beattie; Mohamed Osman; Benjamin M J Owens; Najmeeyah Brown; Jane E Dalton; Asher Maroof; Paul M Kaye
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.